Ambrx Biopharma Inc.

28.00
0.02 (0.07%)
At close: Mar 06, 2024, 9:00 PM

Ambrx Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022
Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
-22.99M -17.83M -15.3M -10.94M -15.57M -28.84M -22.65M
381K 368K 365K 371K 330K 544K 558K
4.82M 2.89M 1.94M 1.19M 1.54M 1.88M 1.65M
-1.52M 1.55M -4.58M -1.54M -953K 2.51M -7.22M
682K 654K 414K 682K 925K 7.58M 3.15M
526K -28K n/a -220K -233K n/a n/a
-2.3M 796K -382K -3.78M -2.77M 4.3M -8.37M
-18.88M -13.15M -12.97M -12.7M -15.78M -14.53M -25.66M
-298K -783K n/a -47K -104K -129K -774K
n/a n/a n/a -8.82M -11.98M n/a n/a
n/a n/a -40.65M -9.42M -12.13M -63.3M n/a
6.46M 9.96M 70.2M 27.21M 11.98M n/a n/a
n/a n/a n/a 8.82M 11.98M n/a n/a
6.16M 9.18M 29.55M 17.74M -252K -63.43M -774K
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
9.71M 82.65M 77.22M 481K 481K -28K -6K
9.71M 82.65M 77.22M 481K 481K -28K -6K
-3M 78.68M 93.81M 4.53M -14.56M -77.99M -26.44M
-19.18M -13.93M -12.97M -12.75M -15.88M -14.66M -26.44M